# Breakthrough CMV Lung Transplant -Multicentre

> **NCT04439916** · — · RECRUITING · sponsor: **University of Alberta** · enrollment: 40 (estimated)

## Conditions studied

- Cytomegalovirus Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04439916
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-25
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04439916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04439916, "Breakthrough CMV Lung Transplant -Multicentre". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04439916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*